SCHEMBL4039735

SCHEMBL4039735

Cc1ccsc1C1([C@@H](C(=O)NC2CCCCC2)C2CCCCC2)Nc2ccc(F)cc2N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
POLB P06746 1/20 0.39
ATM Q13315 1/20 0.38
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
IDO1 P14902 1/20 0.37
PYGL P06737 4/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
KMT2A Q03164 1/20 0.37
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039551 1.00 NPC1 (0.39) NPC1RAB9APOLBATMALPL
SCHEMBL4044722 0.89 RAB9A (0.41) NPC1RAB9AALPLALPIALPG
SCHEMBL4043079 0.78 TSHR (0.40) NPC1RAB9APOLBATMIDO1
SCHEMBL4036796 0.78 NPC1 (0.41) NPC1RAB9APOLBIDO1ALDH1A1
SCHEMBL4036972 0.78 NPC1 (0.41) NPC1RAB9APOLBIDO1ALDH1A1
SCHEMBL4038409 0.78 RAB9A (0.41) NPC1RAB9APOLBKDM4EMEN1
SCHEMBL4034659 0.78 NPC1 (0.43) NPC1RAB9AKDM4EMEN1ALDH1A1
SCHEMBL4040007 0.77 TSHR (0.47) NPC1RAB9APOLBATMIDO1
SCHEMBL4041164 0.77 NPC1 (0.42) NPC1RAB9APOLBIDO1PYGL
SCHEMBL4040710 0.77 NPC1 (0.42) NPC1RAB9APOLBIDO1PYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed